IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...
IRVINE, Calif., Aug. 7, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in the Journal of Anesthesia demonstrates that for fluid responsiveness assessment, Masimo's noninvasive ...
Masimo Corporation MASI recently announced that PVi has obtained FDA approval as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically-ventilated ...
Rugged Handheld Device Provides Clinically Proven Masimo SET® Pulse Oximetry and Respiration Rate Monitoring IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today FDA clearance of ...
Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter. The Rad-G is a handheld device that combines Masimo’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results